- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.11.24 | Applied Tx craters as FDA rejects lead product candidate | ||
| 28.11.24 | FDA probing cancer cases with Bluebird's CALD gene therapy | ||
| 28.11.24 | Study finds AZ's benralizumab a 'game-changer' in asthma | ||
| 28.11.24 | Grifols slides as Brookfield pulls out of takeover talks | ||
| 27.11.24 | Court sides with EU on decision to revoke Ocaliva's license | ||
| 27.11.24 | Trump puts final piece in his MAHA puzzle with NIH nominee | ||
| 27.11.24 | Kisqali gets early breast cancer approval in Europe | ||
| 27.11.24 | Amgen's big reveal of obesity data falls a little flat | ||
| 27.11.24 | NICE backs AZ/Ionis' Wainzua for ATTR polyneuropathy | ||
| 26.11.24 | Biden ramps up Medicare coverage of obesity drugs | ||
| 26.11.24 | Medigene axes staff and refocuses its TCR pipeline | ||
| 26.11.24 | Roche buys off-the-shelf CAR-T player Poseida for $1bn | ||
| 26.11.24 | MSD adds rocket fuel to Winrevair's engine in PAH | ||
| 26.11.24 | End looms for Cassava's simufilam in Alzheimer's disease | ||
| 25.11.24 | Relief for AZ as Truqap hits the spot in prostate cancer | ||
| 25.11.24 | UK digital health funding should be ringfenced, says report | ||
| 25.11.24 | Halozyme abandons its €2bn pursuit of Evotec | ||
| 25.11.24 | Makary confirmed as Trump's FDA pick, with Weldon for CDC | ||
| 25.11.24 | BridgeBio poised to challenge Pfizer after Attruby approval | ||
| 22.11.24 | Neurogene drops high-dose arm in Rett study after death | ||
| 22.11.24 | Neuralink gets okay for its first international trial | ||
| 22.11.24 | Is Martin Makary Trump's pick for FDA Commissioner? | ||
| 22.11.24 | FDA experts lukewarm on AZ's anticoagulant antidote Andexxa | ||
| 22.11.24 | Jazz gets first FDA nod for HER2 bispecific Ziihera | ||
| 21.11.24 | Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
